Continuing Education Courses

Descriptions, course instructors, biographical notes, course description, days/times.
Print

CE-1	Pathology for Non-Pathologists	Jul-15	08:30 - 11:30
	Chair George Cherian (Department of Pathology, University of Western Ontario, Canada) Lesson 1 Methods in Pathology Laura Boone (Principal Research Pathologist, Lilly Research Laboratories, USA) Lesson 2 Cell Injury and Death Colin Rousseaux (Colin Rousseaux and Associates, Canada) Lesson 3 Inflammation and Repair Marie France Perron (MDS Pharma Services, France) Lesson 4 Neoplasia Jeff Engelhardt (Senior Director, Amgen Inc, USA)
CE-2	Development and Interpretation of Toxicokinetic Data for Risk on Safety Assessment	Jul-15	08:30 - 11:30
	Chair John Lipscomb (USEPA National Center for Environmental Assessment) Lesson 1 Use of Compound Specific and General Kinetic Data in Human Risk Assessment John Lipscomb (USEPA National Center for Environmental Assessment) Lesson 2 Physiologically Based Pharmacokinetic Modeling Hugh Barton (Toxicologist, USEPA) Lesson 3 Use of ADME Data in Toxicity Study Design Jos GM Bessems (Senior Scientist, Centre for Substances and Integrated risk Assessment, National Institute for Public Health and the Environment, The Netherlands) Lesson 4 Combining Toxicokinetic and Toxicodynamic Data for Application in Drug Development Rakesh Dixit (Senior Director and Head, Toxicology, Medimmune, USA)
CE-3	"Omics" in Toxicology	Jul-15	08:30 - 11:30
	Chair Barbara Hales (Department of Pharmacology and Therapeutics, McGill University, Canada) Lesson 1 Metabonomics Don Robertson (Director and Research Fellow, Pfizer Global Research and Development, USA) Lesson 2 Genomics Timothy Zacharewski (Department of Biochemistry and Molecular Biology, Michigan State, USA) Lesson 3 Proteomics Mark Garner (Applied Biosystems, Canada Lesson 4 Bioinformatics Michael Hallett (McGill Centre for Bioinformatics, McGill University, Canada)
CE-4	Immunotoxicology	Jul-15	13:30-16:30
	Chair Lynne LeSauteur (Scientific Director, Immunology Laboratory Sciences Charles River Laboratories Montreal, Canada) Lesson 1 Inadvertent Drug Induced Immunostimulation: How it Happens, What it Means Robert House (President/Chief Scientific Officer, DynPort Vaccine Company LLC, USA) Lesson 2 Immunogenicity Validated Assays: Detecting and Characterizing Anti-Drug Antibodies Lynne LeSauteur (Scientific Director, Immunology Laboratory Sciences Charles River Laboratories Montreal, Canada) Lesson 3 A Case Study of Immunostimulatory Recombinant Protein Danuta Herzyk (Senior Scientific Director, Safety Assessment, Safety Assessment, Merck Research Laboratories, USA) and Elizabeth Gore (Investigator, Immunotoxicology, Department of Safety Assessment, GlaxoSmithKline, USA) Lesson 4 Immunotoxicology, Immunomodulation or Immunostimulation: Can T Cells Tell the Difference? Christopher Horvath (Archemix)
CE-5	Balancing Scientific Safety Study and Animal Welfare Refinement, Replacement, and Reduction Objectives	Jul-15	13:30-16:30
	Chair Patricia Turner (University of Guelph, Ontario Veterinary College, Pathobiology, Canada) Lesson 1 Safety Testing and Toxicology Studies: Refining the Humane and Scientific Endpoints Patricia Turner (University of Guelph, Ontario Veterinary College, Pathobiology, Canada) Lesson 2 The Science of Alternatives Allan Goldberg (Johns Hopkins Center for Alternatives to Animal Testing, USA) Lesson 3 Implementation of the Three Rs in Regulatory Testing Gilly Griffin and Allison Guy (Canadian Council on Animal Care, Canada) Lesson 4 Enrichment and Social Housing for Toxicology Research Stephane Goulet (Consultant, Canada)
CE-6	Cardiotoxicity of Non-Cardiac Drugs	Jul-15	13:30-16:30
	Chair Dany Salvail (Director of Pharmacology, IPS Therapeutique Inc, Canada) Lesson 1 Identification of Mechanisms of Cardiotoxicity Using In-Vitro Physiology Experimentation Dany Salvail (Director of Pharmacology, IPS Therapeutique Inc, Canada) Lesson 2 Regulatory Guidelines for Cardiac Safety Testing in Drug Development Colette Strnadova (Health Canada, Therapeutic Products Directorate, Canada) Lesson 3 Methods for in vivo Assessment of Cardiac Toxicity for New Drugs Steve Mason (Charles River Montreal, Canada) Lesson 4 Cardiotoxicity with Therapeutic Drug Levels: The Role of Genetic Background Michael Gollob (Director, Arrhythmia Research Laboratory University of Ottawa Heart Institute, Canada)